Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SUPREME COURT MEDTRONIC V. LOHR RULING LEAVES POSSIBILITY OF TORT CLAIM PREEMPTION BY PMA REQUIREMENTS; PREEMPTION FOR 510(K) DEVICES ELIMINATED

This article was originally published in The Gray Sheet

Executive Summary

The Supreme Court's ruling June 26 in the case of Medtronic v. Lohr includes opinions from five justices that leave open the possibility that premarket approval application requirements could preempt liability claims.

You may also be interested in...



With Scalia’s Passing, Device Industry Loses Preemption Supporter On Supreme Court

Justice Antonin Scalia’s death is not likely to have any immediate impact on the device industry – but at least one observer speculates that, down the road, more cases against manufacturers might be allowed to move forward in the lower courts despite preemption defense.

Wyeth Supreme Court Case Could Have Impact On Device Suits, Lawyers Say

If the Supreme Court favors "implied" federal pre-emption for FDA-approved pharmaceutical labeling in a case that will be heard by the court next month, some devices may receive additional protections too, lawyers suggest

Wyeth Supreme Court Case Could Have Impact On Device Suits, Lawyers Say

If the Supreme Court favors "implied" federal pre-emption for FDA-approved pharmaceutical labeling in a case that will be heard by the court next month, some devices may receive additional protections too, lawyers suggest

Related Content

UsernamePublicRestriction

Register

SC143367

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel